文献速递脑血管病

高龄人群晚发缺血性卒中的病因与预测:ARIC研究

Late-Life Incident Stroke in the Atherosclerosis Risk in Communities Study: Etiology and Prediction.
PubMed 文献 · Stroke · 2026-04-30

基于ARIC队列中6213名无卒中参与者,分析首次急性缺血性卒中(AIS)的病因亚型与预测。中位随访5.1年间277人(4.4%)发生AIS;≥80岁发生AIS者更倾向栓塞性亚型(OR 1.90,95%CI 1.09-3.31),该效应部分由房颤、左房容积指数异常和P波轴异常介导;纳入栓塞危险因素后预测性能改善。

要点

  • ≥80岁发生AIS者栓塞性亚型风险更高,OR 1.90(95%CI 1.09-3.31)。
  • 房颤、左房容积指数异常和P波轴异常部分介导年龄与栓塞性卒中的关联。
  • 现有PREDICT与CHA2DS2-VASc对≥80岁AIS预测差,加入栓塞危险因素后改善。

核心结论

  • 高龄人群AIS以栓塞性亚型更常见,识别和控制栓塞危险因素对降低卒中风险至关重要,仍需更好的卒中专用预测工具。

研究设计与样本

  • ARIC研究:visit 5(2011-2013)无卒中参与者中,病因分析纳入至visit 10(2023)发生AIS者,预测分析纳入visit 5无卒中者。
  • 共6213名无卒中参与者,随访中位5.1年(Q1-Q3 2.6-7.1),277人(4.4%)发生AIS。
  • AIS者中位年龄81岁(Q1-Q3 77-86),女性62%,栓塞性99例、血栓性178例。
  • 采用logistic回归、1000次bootstrap中介分析及C统计量比较预测性能。

主要发现

  • ≥80岁发生AIS者相比<80岁者,栓塞性(对比血栓性)缺血性卒中的比值比为1.90(95%CI 1.09-3.31)。
  • 年龄对栓塞性卒中的效应由房颤介导44%(P=0.03)、左房容积指数异常介导45%(P=0.048)、P波轴异常介导43%(P=0.04)。
  • PREDICT方程预测≥80岁AIS的C统计量0.49(95%CI 0.45-0.53,N=5702),CHA2DS2-VASc为0.57(95%CI 0.55-0.59,N=5739)。
  • 纳入栓塞危险因素后,PREDICT的C统计量升至0.77(95%CI 0.74-0.80),CHA2DS2-VASc升至0.63(95%CI 0.59-0.67)。

临床怎么用

  • 对高龄人群应重视房颤、左房扩大及P波轴异常等栓塞危险因素的识别与控制。
  • 现有通用心血管风险工具对≥80岁AIS预测不佳,纳入栓塞因素可提升判别能力。
  • 临床预测高龄卒中风险时不宜单独依赖PREDICT或CHA2DS2-VASc。

局限性

  • 单队列ARIC研究,AIS事件数有限(277例,其中栓塞性99例)。
  • 中介分析为观察性设计,不能确立因果关系。
  • 预测模型性能比较基于同一队列,外部推广性需验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As life expectancy rises, identifying causes and risk factors for incident acute ischemic stroke (AIS) among the oldest-old (≥80 years) is increasingly important. We examined whether the effect of age at stroke on AIS subtype is mediated by embolic risk factors and whether these factors improve AIS prediction. METHODS: Stroke-free participants from the ARIC study (Atherosclerosis Risk in Communities) who developed AIS between visit 5 (2011-2013) and visit 10 (2023) were included for causal analysis; Stroke-free participants at visit 5 were included for prediction analysis. In logistics regression models, the association between age at stroke-onset (≥80 versus <80 years) and adjudicated AIS subtype (embolic ischemic stroke versus thrombotic ischemic stroke) was determined. Bootstrapped mediation analyses (1000-iterations) tested whether atrial fibrillation, myocardial infarction, coronary heart disease, heart failure, and electro/echocardiogram measures mediated the age-AIS subtype relationship. C statistics were calculated for AIS prediction (Predicting Risk of Cardiovascular Disease Events, CHA2DS2-VASc) and compared preinclusion and postinclusion of embolic risk factors. RESULTS: Of 6213 stroke-free participants at visit 5, 277 (4.4%) developed AIS during a median (Q1-Q3) of 5.1 (2.6-7.1) years (median [Q1-Q3] age: 76 [72-80] years; median [Q1-Q3] age at AIS: 81 [77-86] years; 62% female; 99 embolic ischemic stroke and 178 thrombotic ischemic stroke). Individuals with AIS ≥80 years had higher odds of embolic ischemic stroke (versus thrombotic ischemic stroke) compared with those aged <80 years (odds ratio, 1.90 [95% CI, 1.09-3.31]). The effect of age at stroke-onset on embolic ischemic stroke was mediated by atrial fibrillation (44%; P=0.03), an abnormal left atrium volume index (45%; P=0.048), or an abnormal P-wave axis (43%; P=0.04). The predictive performance for AIS ≥80 years using the Predicting Risk of Cardiovascular Disease Events equation (N=5702, C statistic, 0.49 [95% CI, 0.45-0.53]), or CHA2DS2-VASc score (N=5739, C statistic, 0.57 [95% CI, 0.55-0.59]) was poor, but inclusion of embolic risk factors improved the performance (Predicting Risk of Cardiovascular Disease Events: C statistics, 0.77 [95% CI, 0.74-0.80]; CHA2DS2-VASc: C statistics, 0.63 [95% CI, 0.59-0.67]). CONCLUSIONS: These findings suggest that identification and control of embolic risk factors are critical to reduce stroke risk as people age, and better stroke-specific prediction tools are needed.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Wang J, Egle M, Jin Z, et al. Late-Life Incident Stroke in the Atherosclerosis Risk in Communities Study: Etiology and Prediction. Stroke. 2026. PMID: 42059062. doi:10.1161/STROKEAHA.125.054194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。